MJA
MJA InSight
MJA Careers
Short report

Clinical experience of patients with hepatitis C virus infection among Australian GP trainees

Joshua S Davis, Amanda Tapley, Simon Morgan, Mieke L van Driel and Parker J Magin
Med J Aust 2017; 206 (7): 308-309.
doi:
10.5694/mja16.01106

Since March 2016, new direct-acting antiviral agents (DAAs) for treating infection with hepatitis C virus (HCV) have been available in Australia under the Pharmaceutical Benefits Scheme (PBS). This represents a revolution in the treatment of hepatitis C, as DAA regimens have cure rates of more than 90%, minimal adverse effects, and low treatment complexity. In contrast to previous HCV treatments, general practitioners are authorised to prescribe HCV DAAs.

Joshua S Davis1,2
Amanda Tapley3
Simon Morgan4
Mieke L van Driel5
Parker J Magin6
1 Menzies School of Health Research, Darwin, NT
2 John Hunter Hospital, Newcastle, NSW
3 GP Synergy, Sydney, NSW
4 Elermore Vale General Practice, Newcastle, NSW
5 The University of Queensland, Brisbane, QLD
6 University of Newcastle, Newcastle, NSW
Article References: 
Reference Text: 
Australian Government Department of Health. Fourth national hepatitis C strategy 2014–2017. Canberra: The Commonwealth of Australia, 2014. http://www.health.gov.au/internet/main/publishing.nsf/content/ohp-bbvs-hepc (accessed Nov 2016).
Reference Order: 
1
Reference Text: 
Hajarizadeh B, Grebely J, McManus H, et al. Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatment. J Gastroenterol Hepatol 2017; 32: 229-236.
Reference Order: 
2
Reference Text: 
The Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia. Annual surveillance report 2015. Sydney: The Kirby Institute, 2015. http://kirby.unsw.edu.au/surveillance/2015-annual-surveillance-report-hiv-viral-hepatitis-stis (accessed Oct 2016).
Reference Order: 
3
Reference Text: 
The Burnet Institute. Hepatitis C elimination. 2016. https://www.burnet.edu.au/system/asset/file/2270/Eliminate_Hep_C_Strategy_2016-web.pdf (accessed Oct 2016).
Reference Order: 
4
Reference Text: 
Morgan S, Magin PJ, Henderson KM, et al. Study protocol: the Registrar Clinical Encounters in Training (ReCEnT) study. BMC Fam Pract 2012; 13: 50.
Reference Order: 
5
Reference Text: 
Hays RB, Morgan S. Australian and overseas models of general practice training. Med J Aust 2011; 194: S63-S66.
Reference Order: 
6
Reference Text: 
Hepatitis C Virus Infection Consensus Statement Working Group. Australian recommendations for the management of hepatitis C virus infection: a consensus statement 2016. Melbourne: Gastroenterological Society of Australia, 2016. https://www.asid.net.au/documents/item/1208 (accessed Feb 2017).
Reference Order: 
7

The full contents of this page are only available to subscribers.